Multiple Sclerosis Fellowship Progam
The University of Vermont has had a long-standing interest in
multiple sclerosis, beginning in the 1950's when Dr. George
Schumacher, Chairman of the Department of Neurology, led the
first effort to develop criteria for the diagnosis of MS.
The next Chairman, Dr. Charles Poser was equally well known for his work in MS and other demyelinating diseases of the CNS. This interest was sparked and sustained by the high prevalence of MS in Vermont and adjacent Upstate New York
The MS Center at UVM was re-established in 2001,
under the leadership of Dr. Hillel Panitch, with the intention of
developing a comprehensive MS Center, making the latest forms of
treatment available to the patient population, and conducting
clinical trials of innovative forms of therapy for MS patients in
all stages of the illness.
The UVM MS Center serves approximately 1,500 MS patients in Vermont, New Hampshire and New York. The UVM MS Center is affiliated with the National MS Society and the Consortium of Multiple Sclerosis Centers.
Clinical services are provided by a team of neurologists, clinical nurses, and clinical trial coordinators
working within the University of Vermont Department of Neurological Sciences and the Neurology
Service of UVM Medical Center. Services include diagnostic
consultation, second opinions, long-term follow-up management,
education programs, training in administration of
disease-modifying drugs, a spasticity clinic for patients
receiving intrathecal therapy, other forms of symptomatic
therapy, and an IV infusion program. The UVM MS Center works closely
with neuroradiology, neurosurgery, neuro-ophthalmology, physical
therapy, rehabilitation services, and home nursing agencies to
provide a broad range of patient care. An ongoing research program at the UVM MS Center includes many clinical trials of new MS therapies, as well as translational and basic research to better understand, diagnose, and treat MS.
Andrew J. Solomon, M.D.